1. Home
  2. LIXT vs IMTE Comparison

LIXT vs IMTE Comparison

Compare LIXT & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • IMTE
  • Stock Information
  • Founded
  • LIXT 2005
  • IMTE 2008
  • Country
  • LIXT United States
  • IMTE Malaysia
  • Employees
  • LIXT N/A
  • IMTE N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • IMTE Consumer Electronics/Appliances
  • Sector
  • LIXT Health Care
  • IMTE Consumer Staples
  • Exchange
  • LIXT Nasdaq
  • IMTE Nasdaq
  • Market Cap
  • LIXT 4.1M
  • IMTE 4.1M
  • IPO Year
  • LIXT N/A
  • IMTE N/A
  • Fundamental
  • Price
  • LIXT $1.33
  • IMTE $1.12
  • Analyst Decision
  • LIXT
  • IMTE
  • Analyst Count
  • LIXT 0
  • IMTE 0
  • Target Price
  • LIXT N/A
  • IMTE N/A
  • AVG Volume (30 Days)
  • LIXT 22.1K
  • IMTE 9.9K
  • Earning Date
  • LIXT 05-12-2025
  • IMTE 06-17-2025
  • Dividend Yield
  • LIXT N/A
  • IMTE N/A
  • EPS Growth
  • LIXT N/A
  • IMTE N/A
  • EPS
  • LIXT N/A
  • IMTE N/A
  • Revenue
  • LIXT N/A
  • IMTE $123,337.00
  • Revenue This Year
  • LIXT N/A
  • IMTE N/A
  • Revenue Next Year
  • LIXT N/A
  • IMTE N/A
  • P/E Ratio
  • LIXT N/A
  • IMTE N/A
  • Revenue Growth
  • LIXT N/A
  • IMTE 4.75
  • 52 Week Low
  • LIXT $1.02
  • IMTE $0.51
  • 52 Week High
  • LIXT $3.50
  • IMTE $3.17
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 50.90
  • IMTE 41.83
  • Support Level
  • LIXT $1.16
  • IMTE $1.05
  • Resistance Level
  • LIXT $1.49
  • IMTE $1.13
  • Average True Range (ATR)
  • LIXT 0.11
  • IMTE 0.04
  • MACD
  • LIXT 0.00
  • IMTE -0.00
  • Stochastic Oscillator
  • LIXT 51.45
  • IMTE 35.00

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: